328 related articles for article (PubMed ID: 24641310)
1. Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A.
Simonson B; Morani AS; Ewald AW; Walker L; Kumar N; Simpson D; Miller JH; Prisinzano TE; Kivell BM
Br J Pharmacol; 2015 Jan; 172(2):515-31. PubMed ID: 24641310
[TBL] [Abstract][Full Text] [Related]
2. Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.
Kivell BM; Paton KF; Kumar N; Morani AS; Culverhouse A; Shepherd A; Welsh SA; Biggerstaff A; Crowley RS; Prisinzano TE
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314288
[TBL] [Abstract][Full Text] [Related]
3. The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats.
Morani AS; Ewald A; Prevatt-Smith KM; Prisinzano TE; Kivell BM
Eur J Pharmacol; 2013 Nov; 720(1-3):69-76. PubMed ID: 24201308
[TBL] [Abstract][Full Text] [Related]
4. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.
Kivell B; Uzelac Z; Sundaramurthy S; Rajamanickam J; Ewald A; Chefer V; Jaligam V; Bolan E; Simonson B; Annamalai B; Mannangatti P; Prisinzano TE; Gomes I; Devi LA; Jayanthi LD; Sitte HH; Ramamoorthy S; Shippenberg TS
Neuropharmacology; 2014 Nov; 86():228-40. PubMed ID: 25107591
[TBL] [Abstract][Full Text] [Related]
5. The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects.
Ewald AWM; Bosch PJ; Culverhouse A; Crowley RS; Neuenswander B; Prisinzano TE; Kivell BM
Psychopharmacology (Berl); 2017 Aug; 234(16):2499-2514. PubMed ID: 28536865
[TBL] [Abstract][Full Text] [Related]
6. Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.
Kivell BM; Ewald AW; Prisinzano TE
Adv Pharmacol; 2014; 69():481-511. PubMed ID: 24484985
[TBL] [Abstract][Full Text] [Related]
7. Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone.
Zhou Y; Crowley RS; Ben K; Prisinzano TE; Kreek MJ
Brain Res; 2017 May; 1662():75-86. PubMed ID: 28263712
[TBL] [Abstract][Full Text] [Related]
8. The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.
van de Wetering R; Ewald A; Welsh S; Kornberger L; Williamson SE; McElroy BD; Butelman ER; Prisinzano TE; Kivell BM
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375403
[TBL] [Abstract][Full Text] [Related]
9. MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.
Atigari DV; Uprety R; Pasternak GW; Majumdar S; Kivell BM
Neuropharmacology; 2019 May; 150():217-228. PubMed ID: 30768946
[TBL] [Abstract][Full Text] [Related]
10. 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A.
Wang Y; Chen Y; Xu W; Lee DY; Ma Z; Rawls SM; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2008 Mar; 324(3):1073-83. PubMed ID: 18089845
[TBL] [Abstract][Full Text] [Related]
11. The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice.
Paton KF; Kumar N; Crowley RS; Harper JL; Prisinzano TE; Kivell BM
Eur J Pain; 2017 Jul; 21(6):1039-1050. PubMed ID: 28158929
[TBL] [Abstract][Full Text] [Related]
12. A single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats.
Morani AS; Schenk S; Prisinzano TE; Kivell BM
Behav Pharmacol; 2012 Apr; 23(2):162-70. PubMed ID: 22293826
[TBL] [Abstract][Full Text] [Related]
13. Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity.
Gupta A; Gomes I; Bobeck EN; Fakira AK; Massaro NP; Sharma I; Cavé A; Hamm HE; Parello J; Devi LA
Proc Natl Acad Sci U S A; 2016 May; 113(21):6041-6. PubMed ID: 27162327
[TBL] [Abstract][Full Text] [Related]
14. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
[TBL] [Abstract][Full Text] [Related]
15. Effects of mesyl salvinorin B alone and in combination with naltrexone on alcohol deprivation effect in male and female mice.
Zhou Y; Crowley R; Prisinzano T; Kreek MJ
Neurosci Lett; 2018 Apr; 673():19-23. PubMed ID: 29496608
[TBL] [Abstract][Full Text] [Related]
16. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
[TBL] [Abstract][Full Text] [Related]
17. Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats.
Morani AS; Kivell B; Prisinzano TE; Schenk S
Pharmacol Biochem Behav; 2009 Dec; 94(2):244-9. PubMed ID: 19747933
[TBL] [Abstract][Full Text] [Related]
18. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
[TBL] [Abstract][Full Text] [Related]
19. Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors.
Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
Psychopharmacology (Berl); 2005 May; 179(3):551-8. PubMed ID: 15682306
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
